| 1 |
Prototypes of Lanthanide(III) Agents Responsive to Enzymatic Activities in Three Complementary Imaging Modalities: Visible/Near-Infrared Luminescence, PARACEST-, and T-1-MRI
He JF, Bonnet CS, Eliseeva SV, Lacerda S, Chauvin T, Retailleau P, Szeremeta F, Badet B, Petoud S, Toth E, Durand P
Journal of the American Chemical Society, 138(9), 2913, 2016 |
| 2 |
Expression and purification of active human internal HiS(6)-tagged L-glutamine: D-fructose-6P amidotransferase I
Richez C, Boetzel J, Floquet N, Koteshwar K, Stevens J, Badet B, Badet-Denisot MA
Protein Expression and Purification, 54(1), 45, 2007 |
| 3 |
The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: Implications for structure-based drug design
Greenblatt HM, Guillou C, Guenard D, Argaman A, Botti S, Badet B, Thal C, Silman I, Sussman JL
Journal of the American Chemical Society, 126(47), 15405, 2004 |
| 4 |
Design, Synthesis, and Evaluation of the First-Mechanism-Based Inhibitor of Glucosamine-6-Phosphate Synthase
Massiere F, Badetdenisot MA, Rene L, Badet B
Journal of the American Chemical Society, 119(24), 5748, 1997 |
| 5 |
Characterization of a Phosphoglucose Isomerase-Like Activity Associated with the Carboxy-Terminal Domain of Escherichia-Coli Glucosamine-6-Phosphate Synthase
Leriche C, Badetdenisot MA, Badet B
Journal of the American Chemical Society, 118(7), 1797, 1996 |
